The pharmaceutical industry is willing to pay top dollar for on-premises AI solutions, with some companies shelling out over $500,000 for these systems. But what drives this investment rationale beyond mere compliance? Beyond Compliance In 2025, we s...
Markdown supported · ⌘↵ to post
No responses yet.